139 related articles for article (PubMed ID: 12748463)
1. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
Rosen MP; Breitkopf DM; Nagamani M
Am J Obstet Gynecol; 2003 May; 188(5):1158-60. PubMed ID: 12748463
[TBL] [Abstract][Full Text] [Related]
2. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
3. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
[TBL] [Abstract][Full Text] [Related]
4. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose oral contraceptives on androgenic markers and acne.
Thorneycroft IH; Stanczyk FZ; Bradshaw KD; Ballagh SA; Nichols M; Weber ME
Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776
[TBL] [Abstract][Full Text] [Related]
6. An open study of Triphasil and Diane 50 in the treatment of acne.
Wishart JM
Australas J Dermatol; 1991; 32(1):51-4. PubMed ID: 1834045
[TBL] [Abstract][Full Text] [Related]
7. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
Breitkopf DM; Rosen MP; Young SL; Nagamani M
Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
Bergink EW; Holma P; Pyörälä T
Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
[TBL] [Abstract][Full Text] [Related]
12. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
14. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
Ruutiainen K
Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
[TBL] [Abstract][Full Text] [Related]
15. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
[TBL] [Abstract][Full Text] [Related]
16. A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.
Jaisamrarn U; Chaovisitsaree S; Angsuwathana S; Nerapusee O
Contraception; 2014 Nov; 90(5):535-41. PubMed ID: 25074072
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.
Thiboutot D; Archer DF; Lemay A; Washenik K; Roberts J; Harrison DD
Fertil Steril; 2001 Sep; 76(3):461-8. PubMed ID: 11532465
[TBL] [Abstract][Full Text] [Related]
18. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
Contraception; 2003 Jan; 67(1):25-32. PubMed ID: 12521654
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.
Leyden J; Shalita A; Hordinsky M; Swinyer L; Stanczyk FZ; Weber ME
J Am Acad Dermatol; 2002 Sep; 47(3):399-409. PubMed ID: 12196750
[TBL] [Abstract][Full Text] [Related]
20. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]